Daratumumab cuts risk for progression in multiple myeloma
(HealthDay)—For patients with newly diagnosed multiple myeloma, the addition of daratumumab to lenalidomide and dexamethasone is associated with a reduced risk for disease progression or death, according to a study published ...
May 30, 2019
0
4